April 19, 2022
1 minute read
For the first time in 7 years, the number of STD cases reported in the United States was lower than the previous year. However, the CDC attributed this to a 13% drop in reported chlamydia cases, which was likely the result of underdiagnosis.
The CDC has also seen an alarming increase in congenital syphilis cases, which have risen 235% since 2016. A review of the data was the top infectious disease story last week.
Another headline story was about the Coalition for Epidemic Preparedness Innovations’ “100 Days Mission” plan, which aims to accelerate vaccine development and production during the next pandemic.
Read these articles and more about infectious diseases below:
STDs continue to rise during pandemic, CDC says
The years-long spike in STDs in the United States continued into 2020 in the first year of the COVID-19 pandemic, and there are indications that cases are continuing to rise, the CDC. Read more.
CEPI moon shot: developing pandemic vaccines in 100 days
The Coalition for Epidemic Preparedness Innovations, or CEPI, has launched a multi-billion dollar plan to accelerate the development and production of vaccines for the next pandemic, with the goal of making them available in just 100 days. Read more.
Less than half of people with latent TB in the United States start treatment
The researchers found gaps in the cascade of care for latent TB in the United States, including the fact that less than half of people diagnosed with latent TB in 2016 and 2017 started treatment. Read more.
Stewardship recommendations less likely to be followed when made by a woman, study finds
According to data presented at the Spring Meeting of the Society for Healthcare Epidemiology of America, antibiotic wait times led by female pharmacists were less likely to lead to an antibiotic switch than those led by men. Read more.
Real-time genomic surveillance quickly detects hospital outbreaks
Study results presented at the Society for Healthcare Epidemiology of America Spring Conference continued to show the ability of real-time genomic surveillance to detect nosocomial outbreaks. Read more.